Who owns Oramed Pharm?
- Ticker: ORMP
- CUSIP Number: 68403P203
Tip: Access positions for across all investors
Analyze quarterly positions in Oramed Pharm with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Oramed Pharm stock
Who bought or sold Oramed Pharm this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Murchinson | 1.4M | $4.0M | 100% | Mar 2024 |
|
| BML Capital Management | 845k | $2.5M | -33% | Mar 2024 |
|
| Boothbay Fund Management | 690k | $2.0M | 100% | Mar 2024 |
|
| Susquehanna International | 344k | $1.0M | 2536% | Mar 2024 |
|
| Rathbones Brothers | 290k | $846k | 0% | Mar 2024 |
|
| Bank of America Corporation | 287k | $838k | 6% | Mar 2024 |
|
| Two Sigma Advisers | 264k | $769k | -7% | Mar 2024 |
|
| Two Sigma Investments | 135k | $393k | -15% | Mar 2024 |
|
| BlackRock | 89k | $261k | 1% | Mar 2024 |
|
| Squarepoint Ops | 89k | $260k | -24% | Mar 2024 |
|
| Qube Research & Technologies | 88k | $258k | 792% | Mar 2024 |
|
| Jane Street | 86k | $252k | -10% | Mar 2024 |
|
| D. E. Shaw & Co | 71k | $206k | 19% | Mar 2024 |
|
| LPL Financial | 46k | $133k | 23% | Mar 2024 |
|
| Morgan Stanley | 45k | $131k | -26% | Mar 2024 |
|
| Pnc Financial Services | 26k | $77k | 0% | Mar 2024 |
|
| Geode Capital Management | 26k | $74k | 22% | Mar 2024 |
|
| Virtu Financial | 23k | $68k | 100% | Mar 2024 |
|
| Dimensional Fund Advisors | 21k | $60k | 100% | Mar 2024 |
|
| American Century Companies | 20k | $57k | 4% | Mar 2024 |
|
| Group One Trading | 19k | $56k | 81% | Mar 2024 |
|
| Savvy Advisors | 19k | $55k | 100% | Mar 2024 |
|
| Assenagon Asset Management | 19k | $55k | 100% | Mar 2024 |
|
| Algert Coldiron Investors | 15k | $34k | 0% | Dec 2023 |
|
| Barclays | 13k | $39k | 0% | Mar 2024 |
|
| N.E.W. Advisory Services | 13k | $38k | 0% | Mar 2024 |
|
| Altshuler Shaham | 12k | $35k | -6% | Mar 2024 |
|
| Wealth Enhancement Advisory Services | 11k | $33k | -4% | Mar 2024 |
|
| Close Asset Management | 11k | $33k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 11k | $33k | -61% | Mar 2024 |
|
| Citadel Advisors | 11k | $32k | -75% | Mar 2024 |
|
| Mariner Wealth Advisors | 11k | $31k | 100% | Mar 2024 |
|
| Glass Jacobson Investment Advisors | 11k | $31k | 0% | Mar 2024 |
|
| Journey Strategic Wealth | 10k | $31k | 100% | Mar 2024 |
|
| Steward Partners Investment Advisory | 8.8k | $26k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 7.5k | $22k | 67% | Mar 2024 |
|
| Huntington National Bank | 5.0k | $15k | 0% | Mar 2024 |
|
| Advisor Group Holdings | 4.6k | $14k | -45% | Mar 2024 |
|
| UBS Group | 4.6k | $14k | -8% | Mar 2024 |
|
| Tower Research Capital | 2.7k | $7.8k | 19% | Mar 2024 |
|
| McIlrath & Eck | 2.0k | $5.8k | 0% | Mar 2024 |
|
| Rhumbline Advisers | 1.8k | $5.3k | 0% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 1.6k | $4.6k | 0% | Mar 2024 |
|
| IFP Advisors | 1.5k | $3.5k | -14% | Dec 2023 |
|
| City Holding | 1.1k | $3.1k | 0% | Mar 2024 |
|
| Proequities | 1.0k | $2.9M | 0% | Mar 2024 |
|
| Newbridge Financial Services Group | 657.00 | $1.9k | 0% | Mar 2024 |
|
| Federated Investors | 369.00 | $851.984100 | 202% | Dec 2023 |
|
| Tyler-Stone Wealth Management | 300.00 | $876.000000 | 0% | Mar 2024 |
|
| Beacon Capital Management | 219.00 | $638.998200 | 0% | Mar 2024 |
|
| Global Retirement Partners | 100.00 | $292.000000 | 0% | Mar 2024 |
|
Who sold out of Oramed Pharm?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Hrt Financial | Dec 2023 | 11k | $25k |
| Royal Bank of Canada | Dec 2023 | 9.2k | $21k |
| AJOVista | Dec 2023 | 8.4k | $19k |
| Bourgeon Capital Management | Dec 2023 | 5.6k | $13k |
| LM Advisors | Dec 2023 | 2.5k | $5.8k |
| Quantbot Technologies | Sep 2023 | 931.00 | $2.4k |
| FMR | Sep 2023 | 900.00 | $2.3k |